KTN - Analytical challenges & solutions for medicines manufacturing towards Industry 4.0

The emerging technologies that characterise Industry 4.0 — data connectivity, advanced analytics, robotics and automation — have the potential to revolutionise every element of (bio)pharmaceutical manufacturing within the next five to ten years and are heavily reliant on reliable analytical data.

This one-day meeting, co-organised by CPI and KTN, will consider the challenges highlighted above in the context of the broad range of therapeutic modalities. The agenda will be made up of a number of sessions covering:

  • development of novel sensors and analytical techniques and their regulatory adoption
  • real-time release and process monitoring management of analytical data for small molecules
  • biopharmaceuticals/vaccines and cell and gene therapies.


Chair: Dr Beata Surmacz-Cordle, Lead Scientist - Industrialisation - Analytics

Session 2 - Process Monitoring



The CGT Catapult Industrialisation team will present posters of recent work developing novel analytics approaches for cell and gene therapies.


Find out more and how to register here

Discover who we are